Ħ@HomeĦ@Ħ@HomeĦ@
ĦDnewsĦDĦDclinicĦDĦDlinksĦDĦDsitemapĦD









CGMH
Administration
Center
No.199, Tunghwa Rd.,
Taipei, Taiwan, R.O.C

886-2-27135211
Home > Chang Gung Medical Journal > Vol.25 No.11

Clinical Analysis of 1048 Children with Developmental Delay
I-Chun Chen, MD
Chia-Ling Chen, MD, PhD
May-Kuen Wong, MD
Chia-Ying Chung , MD
Chia-Hui Chen
Chia-Ho Sun

Background: Children with developmental delay (DD) have a variety of problems in developmental functions. The purposes of this study were to analyze the underlying diseases and risk factors in children with different functional delays.
Methods: We collected data on 1048 children who underwent assessments of developmental function, related diseases, and risk factors. All children were classified into 6 functional delay groups: cognitive, speech, motor, pervasive, global, and non-specific DDs. Differences in related diseases and risk factors of the 6 functional delay groups were determined.
Results: Most children had global (51.2%), speech (21.9%), and motor (13.9%) delays. Approximately 62.8% of children were associated with biological factors (19% with genetic defects or congenital anomalies, 16.5% with central nervous system lesions, 13.9% with prematurity/low birth body weight, and 13.4% with neonatal insult). We could not identify the risk factors in 36.6% of the children. Most children with motor delay had brain/neuromuscular diseases and were associated with risks of prematurity or low birth body weight; while most children with global delay had brain neuromuscular diseases or psychological/mental disorders and were associated with risks of genetic defects or congenital anomalies.
Conclusion: Our findings suggest that there are heterogeneous risk factors and related diseases in children with different kinds of functional delay.
(Chang Gung Med J 2002;25:743-50)

Key words: developmental delay, developmental function, risk factor, related disease.

Developmental delay (DD) is simply a chief complaint referring to a condition whereby infants or children do not achieve developmental milestones in 1 or more major streams including motor, perceptual, speech, cognition, and behavior.(1) Children with DD have a variety of developmental dysfunctions; thus, different related diseases may exist. It should be stressed that identifying the underlying diseases as early as possible can provide these children with appropriate service and ongoing surveillance.(2) But few studies have determined the related diseases across the spectrum of early childhood DD subtypes.(3-5)
Early intervention indicates early detection, diagnosis, and rehabilitation training for children with DD. Early intervention not only expands children's developmental capacity but also reduces the social and economic costs and impacts. Thus, it is important to survey the risk factors to be able to identify children who are suspected of having DD at an early stage and subsequently monitor their developmental function. It would be advantageous if it could be determined at an early time whether children suspected of having DD really do have developmental problems and to clarify the range of associated deficits; then clinicians could offer a complete service system for early intervention.(6) A series of steps are included: a thorough evaluation such as medical assessment and psychological testing, a rehabilitation program with physical, occupational, and speech therapy for positioning, handling, feeding, language, and cognitive stimulation, and an educational plan to instruct families in proper functioning.(7) Tirosh et al. suggested that children with fine motor deficits possessed risk factors associated with early antepartum, possibly of genetic origins, while there were few clinical studies to follow up the developmental functions for children with different risk factors.(8-11)
The purposes of this study were to investigate the underlying diseases according to the developmental function and early detection of children with risk factors. We attempted to classify children with DD into functional delay groups based on their developmental dysfunction. Then, we analyzed the related underlying diseases and risk factors in children of different functional delay groups.

METHODS

From October 1998 to September 2000, infants or young children with DD, who were either referred from the Pediatric Department or sent to our clinics for first aid, were recruited into this study. In total, data on 1048 patients were collected in this study. The children underwent an assessment of functional development, related diseases, and risk factors. To assess the functional development, we used the Chinese Children Developmental Inventory (CCDI) to assess 8 functional domains: gross motor, fine motor, expressive language, concept comprehension, social comprehension, self help, personal social, and general development.(12) Based on the clinical assessment combined with the results of the CCDI and other evaluation tests including the Peabody Developmental Motor Scale, Peabody Picture Vocabulary Test, Gross Motor Functional Measure, Wechsler Preschool and Primary Scale of Intelligence, etc, all children were classified into 6 functional delay groups: cognitive, speech, motor, pervasive, global, and non-specific DD. "Significant" was defined as 2 or more standard deviations below the mean of normal references of developmental screening or assessment tests. Cognition involves the high-integrated processes of attention, perception, memory, and functional task performance. Neuropsychological and intelligence tests are helpful in identifying children with cognitive DD. Speech DD indicates a deficit in articulation function, verbal expression, comprehension, or mixtures of the above conditions. Motor DD was defined as a delay in gross motor or fine motor skills with presentation of age-appropriate performances in other developmental domains. Children with core features of observed qualitative deficits in social skills, communication, and repetitive/restrictive patterns of behavior were placed in the pervasive DD group, and those children with visual, hearing, or sensory integration (SI) dysfunction were placed in the non-specific DD group. SI dysfunction results from a disturbance in the integrating process of the subcortical multisensory system. Children whose developmental quotients were less than 80% in 2 or more domains were placed in the global DD group.
To determine the related diseases, children with DD received detailed clinical and laboratory investigations across specialized departments such as neurological (echography, magnetic resonance imaging, computed tomography, electroencephalography, brain auditory evoked potential, etc.), genetic (chromosome, DNA, etc.), metabolic, hearing, or visual studies depending on individual indications. Based on the related diseases ultimately determined by various experts (neurologists, psychiatrists, geneticist, otologists, ophthalmologists, etc), the children with DD were classified into 5 major categories: brain/neuromuscular, psychological/mental, genetic or congenital, visual, hearing, and other diseases. Children with brain lesions (cerebral palsy (CP), hypoxic encephalopathy, microcephaly, central nervous system (CNS) infection, traumatic brain injury, epilepsy, hydrocephalus, tumor, etc.), and neuromuscular diseases (motor neuron disease, peripheral neuropathy, myopathy, etc.) were categorized as having brain/neuromuscular diseases. Children with mental retardation (MR), speech delay, articulation disorder, attention-deficit/hyperactive disorder, SI dysfunction, autism, and non-specific psychomotor retardation were categorized as having psychological/mental disorders. Children with chromosomal or genetic abnormalities, congenital syndromes, metabolic or endocrine diseases, and inborn-error metabolic diseases were categorized as having genetic/congenital diseases. Children with other systemic diseases, such as orthopedic, cardiovascular, digestive, or urinary pathologies, were categorized as having other diseases.
To survey the related risk factors in children with DD, all children underwent detailed birth history taking, chart review, and prospective clinical investigations. The risk factors contributing to DD were categorized into 6 factors: prematurity or low birth body weight (BBW), genetic defects or congenital anomalies, neonatal insult, CNS lesions caused by disease or trauma, environmentally related factors, and unknown causes. A gestational age (GA) below 32 weeks was defined as prematurity, and a BBW of < 2000 g was defined as low BBW. Those who had chromosome or genetic abnormalities, craniofacial anomalies, spinal bifida, congenital heart disease, and limb deformities/deficiencies were categorized into the genetic defect or congenital anomaly group. Neonatal insults included the related factors which had occurred before, during, or after pregnancy, such as low Apgar scores (a score of < 5 at 5 min), infantile spasms, and severe hyperbilirubinemia post-exchange transfusion. CNS lesions consisted of hydrocephalus, intracranial hemorrhage, hypoxic encephalopathy, infection, and seizure disorders. However, we only included parent's mental and psychological disorders as categorized as environmentally related factors in this study. Risk factors not clearly determined were categorized as unknown factors. In addition, the age, body weight (BW), body height (BH), gender, GA, BBW, and delivery modes for the pregnancy were also recorded.
Differences in the continuous data (age, BH, BW, BBW, and GA) among the 6 functional delay groups (cognitive, speech, motor, pervasive, global, and non-specific DD) were compared using ANOVA with Tukey's HSD multiple comparison. Differences in the categorical data (gender, delivery mode, risk factors, and related diseases) among the 6 functional delay groups were determined using Chi-square test. A value of p<0.05 was considered statistically significant.

RESULTS

Based on the geographic distribution, approximately 87% of children came from the Taoyuan area (35.7%) and Taipei area (Taipei County: 29.9%, Taipei City: 21%). The other 13% of children came from other areas (Hsinchu area: 7.4%, Miaoli area: 2.6%, Taichung: 2.1%, and eastern Taiwan: 1.3% including the Keelung, Ilan, and Taitung areas).
According to the assessment of functional development, most children had global (51.2%), speech (21.9%), and motor (13.9%) delays (Fig. 1). The average age of all children with DD at the first visit was 37.8 months, with males dominant (60% vs. 40% (Table 1). The age range of children with speech, pervasive, and non-specific DDs was 45-57 months, while that of children with cognitive, motor, and global delay was approximately 32-33 months. Male dominance (71%-83%) was observed in children with speech, pervasive, and non-specific DDs, but a female dominance (62%) was observed in those with cognitive DD. Tracing the birth history, the average GA of all subjects was 37 weeks, and the BBW was 2834 g. However, the average GA and BBW were lower in children with motor and global delays (motor: 35 weeks, 2546 g; global: 37 weeks, 2701 g). There were no significant differences in the delivery modes (natural spontaneous delivery: 55%, cesarean section: 45%) (Table 1).
When risk factors were analyzed, it was found 62.8% of all children had associated biological factors (20% with genetic defects or congenital anomalies, 16.3% with CNS lesions, 14.2% with prematurity or low BBW, and 13.5% with neonatal insults), and 0.8% of all children were associated with environmental factors (Table 2). However, we could not identify the related risk factors in 35.2% of the children, especially in 48%-72% of children with speech, pervasive, and non-specific DDs. Children with cognitive and global delays were associated with 28%-48% of risks of genetic defects or congenital anomalies, while those with motor delay were associated with 32.4% of risks of prematurity or low BBW (Table 2).
Based on the related diseases in the 6 major categories, our results show that 53.8% of all cases were diagnosed with psychological/mental disorders, 34.4% were diagnosed with brain/neuromuscular diseases, and 7.7% were diagnosed with genetic diseases (Table 3). Approximately 83% of children with motor delay were associated with brain/neuromuscular diseases, while 80% of children with global delay were associated with brain/neuromuscular or psychological/mental disorders (Table 3).

DISCUSSION

Some studies have suggested that the categories of cerebral dysgenesis, hypoxic-ischemic encephalopathy (HIE), antenatal toxin exposure, and chromosomal disorders provided 77% of the diagnoses of children with global DD; 69% of children with motor DD had HIE, cerebral dysgenesis, or benign congenital hypotonia.(3-5) We found that most children (83%) with motor delay were associated with brain/neuromuscular diseases, while most children (80%) with global delay were associated with brain/neuromuscular diseases or psychological/mental disorders. These findings could provide clinicians with clues to investigate the related underlying diseases according to the developmental functions of children. For example, when approaching a child presenting delays in many functional domains, brain or psychological/mental disorders should be considered and evaluated.
We found that children with motor delay were associated with 32.4% of the risks of prematurity or low BBW, even if prematurity or low BBW contributed only 14.2% of the risk to all children with DD. Although prematurity or low BBW is a commonly mentioned risk factor related to DD, the previous literature indicated that it by itself is a relatively weak factor. Approximately 80%-95% of preterm infants are free of severe disabilities.(13-17) The causes and complications of prematurity have been found to be more predictive of developmental outcome than only prematurity.(18) Lindahl et al.(9) found that a small GA, low BBW, and signs of cerebral depression all increased the risk of poor motor performance by about 2-3 fold. Prematurity is well known as a strong risk factor for CP with spastic diplegia.(19,20) Thus, clinicians should closely monitor functional outcomes, especially the motor domain for children with a history of prematurity and low BBW.
In this study, children with cognitive and global delays were associated with 28%-43% of the risks of genetic defects or congenital anomalies, although all children with DD were only associated with 19% of those risks. Previous studies also pointed out that infants with major congenital anomalies had an increased incidence of developmental problems whether there were any associated chromosomal disorders or dysmorphic syndrome.(21,22) Thus, further surveys such as chromosomal, genetic, and metabolic studies are indicated with this clinical approach for infants or children with DD, especially those with cognitive and global delays.
We found the neonatal insults and CNS lesions contributed about 30% of the risk factors in all children with DD. Thus, we should longitudinally follow-up developmental outcomes of children with a history of pre-, peri-, and postnatal insults and investigate CNS dysfunction. Prenatal maternal factors such as drug abuse during pregnancy have been studied and were proven to be associated with intrauterine growth retardation, neonatal withdrawal syndrome, subtle neurological abnormalities, fetal distress, congenital anomalies, and developmental sequelae.(23-25) It is also well known that perinatal asphyxia results in marked symptoms like seizures, coma, lethargy, or muscle tone abnormalities. In studies of severely asphyxiated full-term newborns, 30%-50% died; of those who survived, 12%-30% developed CP or MR.(26-28) Kernicterus appeared to be a low risk factor for DD; our data showed only a 0.5% incidence, but it is still suggested that monitoring be carried out on the developmental outcome of infants whose bilirubin rises to 20-25 or those who have received an exchange transfusion.(7) The data imply that CNS lesions like diffuse encephalomalacia, intraventricular hemorrhage, and intraparenchymal hemorrhage all carry a high risk (70%-90%) of a major handicap in full-term infants.(29) Sepsis complicated with meningitis increased the risk of DD including hearing impairment and congenital infections resulting in CNS injury and long-term developmental sequelae.(30)
We found a relatively low incidence of environment factors in our children, although cognitive delay was associated with 14.3% of environmental factors. While previous studies conducted before 1989 reported that cognitive and speech/language disorders were prevalent among children of parents with a low educational level or low social class,(9-11,31) this discrepancy may possibly have been caused by the patient classification, definitions of environment factors, Chinese culture, risk factor categorization, and genetic technology improvements among studies. In this study, all children with pervasive delays were autistic, and most children with speech delays had articulation disorders. Environmental factors only included the parental MR or psychological disorders and child abuse, and did not include low educational level or low social class. In Chinese culture, people usually do not mention any family history of MR, psychological disorders, or child abuse. Thus, it is possible that the environmental factors were underestimated in this study. Only 1 major risk factor was selected for statistical analysis, and there may have been several risk factors coexisting simultaneously. The risk factors were categorized into biological factors such as genetic defects, congenital anomalies, neonatal insults, and CNS lesions if combined with environmental factors. Environment factors categorized before 1990 might have been re-categorized into genetic defects or congenital anomalies due to rapid improvements in molecular biology and genetic technology in recent years. Thus, the determined risk of genetic defects or congenital anomalies was relatively increased, and that of environmental factor was relatively decreased in this study.
This study shows there are heterogeneous risk factors and related diseases in children with different functional delays. These findings provide clues from which to investigate underlying diseases according to developmental function and a comprehensive assessment and to follow up the specific functional outcomes in children with different risk factors. It is worthwhile and beneficial to identify and provide therapeutic intervention as early as possible to decrease disabilities and family stress in children with DD. Further efforts should stress the development of a referral organization which integrate aspects of medical, educational, and social affairs units.

REFERENCES

1. Petersen MC, Kube DA, Palmer FB. Classification of developmental delays. Semin Pediatr Neurol 1998;5:2-14.
2. First LR, Palfrey JS. The infant or young child with developmental delay. N Engl J Med 1994;330:478-83.
3. Shevell MI, Majnemer A, Rosenbaum P, Abrahamowicz M. Etiologic determination of childhood developmental delay. Brain Dev 2001;23:228-35.
4. Shevell MI, Majnemer A, Rosenbaum P, Abrahamowicz M. Etiologic yield of subspecialists' evaluation of young children with global developmental delay. J Pediatr 2000;136:593-8.
5. Shevell MI, Majnemer A, Rosenbaum P, Abrahamowicz M. Etiologic yield of single domain developmental delay: a prospective study. J Pediatr 2000;137:633-7.
6. Levy SE, Hyman SL. Pediatric assessment of the child with developmental delay. Pediatr Clin North Am 1993;40:465-77.
7. Allen MC. The high-risk infant. Pediatr Clin North Am 1993;40:479-90.
8. Tirosh E. Fine motor deficit: an etiologically distinct entity. Pediatr Neurol 1994;10:213-6.
9. Lindahl E, Michelsson K, Helenius M, Parre M. Neonatal risk factors and later neurodevelopmental disturbances. Dev Med Child Neurol 1988;30:571-89.
10. Calame A, Reymond-Goni I, Maherzi M, Roulet M, Marchand C, Prod'hom LS. Psychological and neurodevelopment outcome of high risk newborn infants. Helv Paediatr Acta 1976;31:287-97.
11. Ounsted M, Moar VA, Scott A. Factors affecting development: similarities and differences among who were small, average, and large for gestational age at birth. Acta Paediatr Scand 1986;75:261-6.
12. Hsu CC, Su S, Shao SJ, Lin CC, Soong WT, Chang C. Chinese child developmental inventory: a tentative normative data. Acta Pediatrica Sinica 1978;19:142-57.
13. Aylward GP, Pfeiffer SI, Wright A, Verhulst SJ. Outcome studies of low birth weight infants published in the last decade: a meta-analysis. J Pediatr 1989;115:515-20.
14. Teplin SW, Burchinal M, Johnson-Martin N, Humphry RA, Kraybill EN. Neurodevelopmental, health, and growth status at age 6 years of children with birth weights less than 1001 grams. J Pediatr 1991;118:768-77.
15. Escobar GJ, Littenberg B, Petitti DB. Outcome among surviving very low birthweight infants: a meta-analysis. Arch Dis Child 1991;66:204-11.
16. Kitchen WH, Ryan MM, Rickards A, McDougall AB, Billson FA, Keir EH, Naylor FD. A longitudinal study of very low-birthweight infants. IV: An overview of performance at eight years of age. Dev Med Child Neurol 1980;22:172-88.
17. Nickel RE, Bennett FC, Lamson FN. School performance of children with birth weights of 1000g or less. Am J Dis Child 1982;136:105-10.
18. Drillien CM, Thomson AJ, Burgoyne K. Low-birthweight children at early school age: A longitudinal study. Dev Med Child Neurol 1980;22:26-47.
19. Fritsch G, Haidvogl M. Pre- and perinatal risk factors in the etiology of infantile cerebral palsy. Int J Rehabil Res 1982;5:19-26.
20. Binder H, Eng GD. Rehabilitation management of children with spastic diplegic cerebral palsy. Arch Phys Med Rehabil 1989;70:482-9.
21. Drillien CM. The small-for-date infant: Etiology and prognosis. Pediatr Clin North Am 1970;17:9-24.
22. Jones KL. Smith's Recognizable Patterns of Human Malformation. 5th ed. Philadelphia: WB Saunders, 1997:681-7.
23. Lifschitz MH, Wilson GS, Smith EO, Desmond MM. Factors affecting head growth and intellectual function in children of drug addicts. Pediatrics 1985;75:269-74.
24. Bandstra ES, Burkett G. Maternal-fetal and neonatal effects of in utero cocaine exposure. Semin Perinatol 1991;15:288-301.
25. Doberczak TM, Shanzer S, Senie RT, Kandall SR. Neonatal neurologic and electroencephalographic effects of intrauterine cocaine exposure. J Pediatr 1988;113:354-8.
26. Ishikawa T, Ogawa Y, Kanayama M, Wada Y. Long-term prognosis of asphyxiated full-term neonates with CNS complications. Brian Dev 1987;9:48-53.
27. Nelson KB, Ellenberg JH. Apgar scores as predictors of chronic neurological disability. Pediatrics 1981;68:36-44.
28. Brown JK, Purvis RJ, Forfar JO, Cockburn F. Neurological aspects of perinatal asphyxia. Dev Med Child Neurol 1974;16:567-80.
29. Fitzhardinge PM, Flodmark O, Fitz CR, Ashby S. The prognostic value of computed tomography as an adjunct to assessment of the term infant with postasphyxial encephalopathy. J Pediatr 1981;99:777-81.
30. Remington JS, Klein JO. Infectious Diseases of the Fetus and Newborn Infant. 4th ed. Philadelphia: WB Saunders, 1995:4-875.
31. Bendel J, Palti H, Winter S, Ornoy A. Prevalence of disabilities in a national sample of 3-years-old Israeli children. Isr J Med Sci 1989;25:264-70.

From the Department of Rehablitaion, Chang Gung Memorial Hospital, Taipei.
Received: Jan. 17, 2002; Accepted: Aug. 12, 2002
Address for reprints: Dr. Chia-Ling Chen, Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital. 5 Fu-Shing St., Kweishan, Taoyuan 333, Taiwan, R.O.C. Tel.: 886-3-3281200 ext. 8147; Fax: 886-3-3281200 ext. 2667; E-mail: a7634245@ms21.hinet.net

 
Ħ@comming soonĦ@
 back  top
 back  top ĦDTraditional ChineseĦD ĦDSimplified ChineseĦD